Abstract:Hepatocellular carcinoma (HCC) is one of the deadliest cancers worldwide due to the lack of effective therapy methods. Therefore, there is an urgent need to develop novel therapies for HCC. CBL0137 is a small molecule that affects p53 and nuclear factor-kappa B (NF-κB). The expression of p53 was measured by using immunohistochemistry (IHC) in tumor and adjacent tissues. Western blotting (WB) and quantitative real-time polymerase chain reaction (qRT-PCR) were employed to detect the level of p-p53, p53, Bax, and PUMA after CBL0137 administration. CCK-8 and immunofluorescence staining (IF) assays were performed to evaluate the proliferation and viability of HCC cells. Flow cytometry was used to detect the apoptosis of HCC cells. Xenograft model was established to determine the effect of CBL0137 treatment on HCC tumor growth in vivo. HE staining was used to monitor HCC cell morphology and IHC staining for Ki-67 was performed to determine the tumor cell proliferation following CBL0137 treatment. Results showed that the expression of p-p53, p53, Bax, and PUMA was upregulated after CBL0137 administration. The viability, growth, and colony formation of HCC cells were significantly inhibited by CBL0137 in the CBL group compared with the NC group (p<0.05). Meanwhile, the results revealed that the proportions of apoptotic and necrotic cells were significantly elevated in the CBL group compared to the NC group (p<0.05). And the apoptosis-related proteins including PARP, caspase-3, caspase-7, caspase-8, and caspase-9 were increased in the CBL group compared with the NC group (p<0.05), while the NF-κB, p-NF-κB and p-AKT expression levels were significantly downregulated following CBL0137 treatment (p<0.05). Additionally, the tumor volume and weight were significantly reduced in the CBL group compared with the NC group (p<0.05). Moreover, HE staining and IHC staining for Ki-67 indicated that CBL0137 treatment could obviously induce cell apoptosis and suppress cell proliferation. CBL0137 treatment could effectively inhibit HCC cell proliferation and induce cell apoptosis associated with multiple factors expression.

Introduction of G1 phase arrest in Human Hepatocellular carcinoma cells (HHCC) by APMCF1 gene transfection through the down-regulation of TIMP3 and up-regulation of the CDK inhibitors p21

STAT1 Inhibits Human Hepatocellular Carcinoma Cell Growth Through Induction of P53 and Fbxw7

Subcellular Localization of APMCF1 and Its Biological Significance of Expression Pattern in Normal and Malignant Human Tissues

CBL0137 Administration Suppresses Human Hepatocellular Carcinoma Cells Proliferation and Induces Apoptosis Associated with Multiple Cell Death Related Proteins.

TIMP-3 acts as suppressor gene in hepatocarcinoma

NCPMF-60 Induces G2/M Cell Cycle Arrest and Apoptosis in Human Hepatocellular Carcinoma HepG2 Cells

The overexpression of MCPH1 inhibits cell growth through regulating cell cycle-related proteins and activating cytochrome c-caspase 3 signaling in cervical cancer

Hepatopoietin Cn Suppresses Apoptosis of Human Hepatocellular Carcinoma Cells by Up-Regulating Myeloid Cell Leukemia-1.

FHIT Promotes the Apoptosis of QBC939 by Reducing the Expression of Cyclin D1.

Expression and Inhibitory Role of TIMP-3 in Hepatocellular Carcinoma.

MicroRNA-377-3p Promotes Cell Proliferation and Inhibits Cell Cycle Arrest and Cell Apoptosis in Hepatocellular Carcinoma by Affecting EGR1-mediated P53 Activation.

The Effect of Fragile Histidine Triad Gene on the Apoptosis of Cholangiocarcinoma Cells

Effects of Apr-1 Gene on Cell Cycle Regulation of Cholangiocarcinoma QBC939 Cell Lines

Timp-1 Activated Carcinoma-Associated Fibroblasts Inhibit Tumor Apoptosis by Activating Sdf1/Cxcr4 Signaling in Hepatocellular Carcinoma

Molecular Chaperone CCT3 Supports Proper Mitotic Progression and Cell Proliferation in Hepatocellular Carcinoma Cells.

Effect of Microrna-150 Up-Regulation on Proliferation and Apoptosis of Hepatocellular Carcinoma Cell Line SMMC-7721

Effects of HMGA1 silence by RNA interference on the apoptosis and cell cycle of hepatocarcinoma cells

Silencing non-SMC chromosome-associated polypeptide G inhibits proliferation and induces apoptosis in hepatocellular carcinoma cells

EFFECTS OF P53 ON GROWTH AND CYCLE RELATIVE GENES OF MCF-7 BREAST CANCER CELLS

Differential regulation of P53, c-Myc, Bcl-2, Bax and AFP protein expression, and caspase activity during 10-hydroxycamptothecin-induced apoptosis in Hep G2 cells:

Effects of cancer-testis antigen, TFDP3, on cell cycle regulation and its mechanism in L-02 and HepG2 cell lines in vitro